Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol for Pruritus in Children With Hereditary Epidermolysis Bullosa
NCT05651607Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2023
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabidiol in pruritus, sponsored by Assistance publique - Hôpitaux de Paris. Started Sep 2023; status: completed.
02
Drugs
cannabidiol
03
Conditions
pruritus
Beyond the preview
Go deeper on NCT05651607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05651607.